TYK2 Inhibitors

TYK2 inhibitors are used to treat plaque psoriasis. They work by binding to the tyrosine kinase 2 protein and preventing the activation of a downstream inflammatory response.

Why are tyk2 inhibitors prescribed?

Plaque Psoriasis (50%)
Psoriatic Arthritis (50%)

How are these percentages calculated?

Key takeaways

TYK2 inhibitors are typically used to treat moderate-to-severe plaque psoriasis. TYK2 inhibitors work by blocking the activity of the TYK2 enzyme, which plays a role in the immune system and inflammation. These medications are typically available as oral pills. A main example is Sotyktu (deucravacitinib).

Prices for popular TYK2 Inhibitors medications

Viewing 1 of 1 medications

Sotyktu

Sotyktu (deucravacitinib) is used for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Sotyktu is a Tyrosine Kinase 2 (TYK2) Inhibitor, which works by binding to the tyrosine kinase 2 protein and preventing the activation of a downstream inflammatory response. Sotyktu is available as a 6mg tablet. There are currently no generic alternatives for Sotyktu. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.

See prices More info

Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.